Category: Health

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor

Researchers at Japan’s National Institutes for Quantum Science and Technology (QST) have found that tau buildup in progressive supranuclear palsy (PSP) may affect brain networks

Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies such as ECT and Repetitive Transcranial Magnetic Stimulation (rTMS)

Chronic hepatitis B virus (HBV) infection remains a major cause of global liver morbidity, leading to progressive necroinflammation that often culminates in cirrhosis and hepatocellular

A new study, using Mongolian gerbils as an animal model, demonstrated for the first time that trans-tympanic infrared laser stimulation of the cochlea evokes reliable

The families of two men who discovered through DNA tests that they were switched at birth 38 years ago are accusing a North Dakota hospital

Cases caused by the amoeba, Naegleria fowleri, have numbered in the hundreds since 1960 – but it can quickly prove fatal if not diagnosed correctly.

All newborn babies in England will be tested for the genetic disease spinal muscular atrophy (SMA), as part of a major study.

The nine types of stalling that researchers say can reveal something deeper about us and why it’s not always bad.

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

Karina Acton Reid recounts caring for her husband with young-onset Alzheimer’s disease presenting as posterior cortical atrophy while raising two young children. Her perspective shows

For decades, medicine has chased a simple but elusive goal of delivering the right drug to the right place at the right time.

Cancer treatments like radiation and chemotherapy work by doing one main thing: shredding the DNA of cancer cells so they can no longer multiply.

Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers